• HOME
  • ABOUT ACORDA
  • FOR PATIENTS
  • PRODUCTS & RESEARCH
  • INVESTORS
  • NEWS & EVENTS
  • CAREERS
  • Message
    From Our CEO
  • Company
    Leadership
  • Board
    of Directors
  • Our
    Employees
  • Partnering
    With Acorda
  • Grant
    Program
  • Our Focus
    on Therapies
  • In the
    Community
  • Patient
    Assistance
  • Resources
  • Clinical
    Trials
  • Product
    Pipeline
  • AMPYRA®
    (Dalfampridine)
  • ZANAFLEX
    CAPSULES®
    (Tizanidine HCl)
  • Diazepam
    Nasal Spray
  • AC105
  • GGF2
  • rHIgM22
  • Chondroitinase
  • Corporate
    Profile
  • Stock Quote/
    Chart
  • Investor
    Events
  • Press
    Releases
  • SEC
    Filings
  • E-mail
    Alerts
  • In the News
  • Awards
  • Press
    Releases
  • Company
    Events
  • Working at
    Acorda
  • Benefits
  • Job
    Openings
  • Application

  • Tuesday, May 21, 2013

    Acorda Therapeutics Announces Publication of New Data on Impact of Mobility...

  • Awards
Kris Christian and Michele Gordon...
...discuss what makes Acorda a unique place to work
See the Video

ABOUT ACORDA

FOR PATIENTS

PRODUCTS & RESEARCH

INVESTORS

NEWS & EVENTS

CAREERS

  • Privacy Policy
  • Terms of Use
  • Site Map
  • Contact Us